Session 6: MAT and Urine Drug Testing
Back to course
Video Transcription
Video Summary
buprenorphine induction
medication options
urine drug testing
opioid-dependent patient
stabilization on buprenorphine
patient education
buprenorphine-naloxone combination products
urine drug testing importance
The content on this site is intended solely to inform and educate medical professionals. This site shall not be used for medical advice and is not a substitute for the advice or treatment of a qualified medical professional.

Funding for this initiative was made possible by cooperative agreement no. 1H79TI086770 and grant no. 1H79TI085588 from SAMHSA. The views expressed in written conference materials or publications and by speakers and moderators do not necessarily reflect the official policies of the Department of Health and Human Services; nor does mention of trade names, commercial practices, or organizations imply endorsement by the U.S. Government.

8-Hour DEA Training Inquiries, email PCSS-MOUD.


Powered By